about
Histologic scoring indices for evaluation of disease activity in ulcerative colitisRectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitisRectal 5-aminosalicylic acid for induction of remission in ulcerative colitisThickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitisRetarded release phosphatidylcholine benefits patients with chronic active ulcerative colitisEosinophils in infection and intestinal immunityInfluence of treatment on morphological features of mucosal inflammationLow dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapsesHistologic scoring indices for evaluation of disease activity in ulcerative colitis.Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.The proinflammatory CXC-chemokines GRO-alpha/CXCL1 and MIG/CXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids.Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN)Histological healing favors lower risk of colon carcinoma in extensive ulcerative colitis.Eosinophils in Autoimmune Diseases.Cytomegalovirus infection in severe ulcerative colitis patients undergoing continuous intravenous cyclosporine treatment in JapanNitric oxide mediates a therapeutic effect of nicotine in ulcerative colitis.Relationship between methylation and colonic inflammation in inflammatory bowel disease.Comparison of bismuth citrate and 5-aminosalicylic acid enemas in distal ulcerative colitis: a controlled trial.Microscopic activity in ulcerative colitis: what does it mean?Optimum dosage of 5-aminosalicylic acid as rectal enemas in patients with active ulcerative colitisMucosal enzyme activity for butyrate oxidation; no defect in patients with ulcerative colitis.Olsalazine in active ulcerative colitis.Circulating levels of sulphasalazine and its metabolites and their relation to the clinical efficacy of the drug in ulcerative colitisOptimum dose of sulphasalazine for maintenance treatment in ulcerative colitis.Crypt cell production rate in ulcerative proctocolitis: differential increments in remission and relapseControlled trial comparing olsalazine and sulphasalazine for the maintenance treatment of ulcerative colitisOlsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind studyPlasma fibronectin in Crohn's disease.Olsalazine versus placebo in the treatment of mild to moderate ulcerative colitis: a randomised double blind trial.Antioxidant properties of mesalamine in colitis inhibit phosphoinositide 3-kinase signaling in progenitor cells.THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS. III. COMPLICATIONSPersistence of mucosal abnormality in ulcerative colitisHistamine content of rectal mucosa in ulcerative colitis.Characteristics and therapeutic efficacy of sulfasalazine in patients with mildly and moderately active ulcerative colitis.Pathology of inflammatory bowel diseases (IBD): variability with time and treatment.Assessment of histologic disease activity in Crohn's disease: a systematic review.Sulphation and secretion of the predominant secretory human colonic mucin MUC2 in ulcerative colitis.Thiol methyltransferase activity in inflammatory bowel disease.Impairment of epithelial transport but not of barrier function in idiopathic pouchitis after ulcerative colitis.Effects of sulfasalazine on biopsy mucosal pathologies and histological grading of patients with active ulcerative colitis.
P2860
Q24194674-6368BC0D-9982-490B-97B2-B1AABB87EE10Q24202978-ABFB2ADE-7287-42D6-8AA0-87CD6009CE98Q24240567-9C7660FA-5FAD-43BE-BF58-A2F58058E694Q24537963-4ED66C28-8E78-4F5F-9F2B-9EA250EA28FDQ24685584-C69CEC29-5874-4A43-A1E3-B1B1D7CD9912Q27028076-1C6C0198-D35B-40CD-8D4B-20509FAAEACAQ28192791-4125B18A-25C0-4392-90EE-F3725C1CC094Q28205383-81EC754C-EAE1-4518-B68C-B13BAD16E0FEQ30234366-FC8B7112-AE2F-4282-A17A-122D997A1681Q30581062-5B720315-6FD8-4917-B247-0FB7460A5229Q33294346-D48B5E44-E449-4E93-B34C-B7FDB4609125Q33557634-B072F97A-D096-4266-A9E7-B0A89E72BA5FQ33564132-45482B1F-16BA-4C5E-964B-021AA99061FFQ33607031-0A2CE392-3D14-444F-AC73-D2ABB6B54C3BQ33788037-A3BDDBBB-582B-4CD3-B671-522C695D2457Q33924549-C7A50609-9A21-4112-9CD4-E4AC9507EA52Q34036817-CA65B9CA-56EA-46AD-B7B7-6103E5495908Q34376627-1B288ED2-CFDF-4283-9386-D4B4A3AD1069Q34393414-A2386F8D-C1F0-4015-908D-367252224628Q34394096-3CBCEB66-FBED-469D-BE2B-3A780465555CQ34409826-E313AD3F-D219-493F-9EE6-D279F4E3AB16Q34492974-0549CCA2-E0C3-4C22-84D1-6985A1640DBCQ34493372-311EF8DF-1931-4CA3-9E86-E7D0045DB92CQ34496962-2B181D98-E8E0-407D-BF5A-0DFDB68CCE94Q34527780-637F8EC2-9665-42CB-B19B-FAB20B34385BQ34530392-798D56E6-EF19-4039-A0BE-AF0FD7AC61BAQ34532266-8C934302-AA21-46EB-9A51-539A0F9DEE69Q34532287-23D23B5C-EC2F-48BB-AB0C-E774FC68CB91Q34532732-E035FF38-9216-465B-AFE5-7846D4B62CD8Q34836490-4B20AD70-F265-4D51-80E7-62E372DA7979Q35002356-65AF8D09-5190-465C-99C1-CA886F96D00AQ35002858-6E47AB3B-700A-4EB2-81CB-2252EBD514EAQ35002913-600B86F3-CEAA-4E03-A9E4-58B79654554CQ35010202-3E26E38E-F07F-40DC-955C-F2927CB6247BQ35147234-AEA8EF04-0149-4AC3-ACBE-DB8DDA5E543DQ35228055-401BBD28-2BA0-4063-9719-5A4BD7F398FCQ35354507-951273E1-7B73-4440-9EB8-7EF69E796B59Q35360791-750E924D-2228-4ACB-B452-145926E48259Q35594644-0A8D45DA-8DD9-43F8-AD27-476D8C240F3AQ35615974-8162C61F-538B-40CD-83EC-7FF9135687B9
P2860
description
1956 nî lūn-bûn
@nan
1956年の論文
@ja
1956年学术文章
@wuu
1956年学术文章
@zh
1956年学术文章
@zh-cn
1956年学术文章
@zh-hans
1956年学术文章
@zh-my
1956年学术文章
@zh-sg
1956年學術文章
@yue
1956年學術文章
@zh-hant
name
Biopsy studies in ulcerative colitis.
@en
Biopsy studies in ulcerative colitis.
@nl
Studium biopsií u ulcerózní kolitidy
@cs
type
label
Biopsy studies in ulcerative colitis.
@en
Biopsy studies in ulcerative colitis.
@nl
Studium biopsií u ulcerózní kolitidy
@cs
prefLabel
Biopsy studies in ulcerative colitis.
@en
Biopsy studies in ulcerative colitis.
@nl
Studium biopsií u ulcerózní kolitidy
@cs
P2860
P356
P1433
P1476
Biopsy studies in ulcerative colitis.
@en
P2093
RICHARDS WC
TRUELOVE SC
P2860
P304
P356
10.1136/BMJ.1.4979.1315
P407
P577
1956-06-01T00:00:00Z